Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Cyclacel Pharma (CYCC) Tops Q1 EPS by 13c
May 12, 2020 4:28 PM EDTCyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($2.77), $0.13 better than the analyst estimate of ($2.90).
The global pandemic is creating uncertainty in every business sector and it is clear that we need novel, science-based solutions to emerge from the crisis, said Spiro Rombotis, President and Chief... More
